Abstract
The corneal endothelium plays a key role in the physiology of the cornea, maintaining its transparency by regulating corneal hydration. Moreover, corneal endothelial cells play the central role in irreversible corneal graft rejection as human corneal endothelial cells are predominantly postmitotic, and destroyed cells cannot be replaced. Therefore, gene transfer to the corneal endothelium to modify the corneal immune response for prophylaxis of corneal endothelial rejection has become a fast-developing research field. An addition pivotal advantage of gene transfer to the cornea is the possibility of ex vivo transfection during organ culturing, minimizing the risk of systemic spread of the vector or the transgene expression. A wide variety of vectors has been found suitable for gene transfer to the corneal endothelium, and therapeutic efficacy has been demonstrated in some experimental models of corneal disease. However, the transfection efficiency varies widely among the different vectors, and the optimal transfection efficiency to provoke a desired effect is still unclear. Moreover, it certainly depends on the biological function of the chosen transgene (cytokine, growth factor, etc.). As a consequence, relatively few studies have been able to demonstrate significant prolongation of corneal allograft survival after gene transfer to the endothelium, and the ideal transfer strategy has not been found. In contrast, different transfer strategies compete today, each with its special advantages and disadvantages. Physical, viral, and nonviral techniques have been used to transfer transgenes into endothelial cells. In the introduction of this chapter, a short overview of the different gene transfer strategies for endothelial cells is given; the materials and methods sections describe in detail the most widely used viral gene transfer technique (adenoviral) and an important nonviral alternative technique (liposomal transfection) to endothelial cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Larkin, D. F. P., Oral, H. B., Ring, C. J. A., Lemoine, N. R., George, A. J. T. (1996) Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 61, 363–370.
Fehervari, Z., Rayner, S. A., Oral, H. B., George, A. J. T., Larkin, D. F. P. (1997) Gene transfer to ex vivo stored corneas. Cornea 16, 459–464.
Oral, H. B., Larkin, D. F. P., Fehervari, Z., (1997) Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther 4, 639–647.
Arancibla-Carcamo, C. V., Oral, H. B., Haskard, D. O., Larkin, D. F. P., George, A. J. T. (1998) Lipoadenofection-mediated gene delivery to the corneal endothelium. Transplantation 65, 62–67.
Ritter, T., Vogt, K., Rieck, P., (1999) Adenovirus-mediated gene transfer of IL-4 to corneal endothelial cells and organ cultured corneas leads to high IL-4 expression. Exp Eye Res 69, 563–568.
Pleyer, U., Ritter, T. (2003) Gene therapy in immune-mediated diseases of the eye. Prog Ret Eye Res 22, 277–293.
Stechschulte, S. U., Joussen, A. M., von Recum, H. A., (2001) Rapid ocular angiogenic control via naked DNA delivery to the cornea. Invest Ophthalmol Vis Sci 42, 1975–1979.
Moore, J. E., McMullen, T. C., Campbell, I. L., (2002) The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1RA gene therapy. Invest Ophthalmol Vis Sci 43, 2905–2915.
Williams, K. A., Jessup, C. F., Coster, D. J. (2004) Gene therapy approaches to prolonging corneal allograft survival. Expert Opin Biol Ther 4, 1059–1071.
Davies, J. B., Ciavatta, V. T., Boatright, J. H., Nickerson, J. M. (2003) Delivery of several forms of DNA, DNA-RNA hybrids, and dyes across human sclera by electrical fields. Mol Vis 9, 569–578.
Oshima, Y., Sakamoto, T., Hisatomi, T. (2002) Targeted gene transfer to corneal stroma in vivo by electric pulses. Exp Eye Res 74, 191–198.
Tanelian, D., Barry, M. A., Johnston, S. A., Le, T., Smith, G. (1997) Controlled gene gun delivery and expression of DNA within the cornea. BioTechniques 23, 484–488.
Klebe, S., Stirling, J. W., Williams, K. A. (2000) Corneal endothelial cell nuclei are damaged after DNA transfer using a gene gun. Clin Exp Ophthalmol 28, 58–59.
Pleyer, U., Groth, D., Hinz, B., (2001) Efficiency and toxicity of liposome-mediated gene transfer to corneal endothelial cells. Exp Eye Res 73, 1–7.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gonczol, E., Wilson, J. M. (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 91, 4407–4411.
Somia, N., Verma, I. M. (2000) Gene therapy: trials and tribulations. Nat Rev Genet 1, 91–99.
Hudde, T., Rayner, S. A., De Alwis, M., (2000) Adeno-associated and herpes simplex viruses for gene transfer to the corneal endothelium. Cornea 19, 369–373.
Tsai, M. L., Chen, S. L., Chou, P. I., Wen, L. Y., Tsai, R. J. F., Tsao, Y. P. (2002) Inducible adeno-associated virus vector delivered transgene expression in corneal endothelium. Invest Ophthalmol Vis Sci 43, 751–757.
Klebe, S., Sykes, P. J., Coster, D. J., Bloom, D. C., Williams, K. A. (2001) Gene transfer to ovine corneal endothelium. Clin Exp Ophthalmol 29, 316–322.
Wang X, Appukuttan B, Ott S. (2000) Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector. Gene Ther 7, 196–200.
Bainbridge, J. W., Stephens, C., Parsley, K., (2001) In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther 8, 1665–1668.
Felgner, P. L., Gadek, T. R., Holm, M., (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 84, 7413–7417.
Dannowski, H., Bednarz, J., Reszka, R., Engelmann, K., Pleyer, U. (2005) Lipid-mediated gene transfer of acidic fibroblast growth factor into human corneal endothelial cells. Exp Eye Res 80, 93–101.
Blumenthal, R., Ralston, E., Dragsten, P. (1982) Lipid vesicle-cells interactions: analysis of a model for transfer of contents from adsorbed vesicles to cells. Membr Biochem 4, 283–303.
New, R. R. G., Black, C. D. V., Parker, R. J. (1990) Liposomes in biological systems, in New (ed), R. R. C.. Liposomes, a Practical Approach. Oxford University Press, New York .
Martin, A., Clynes, M. (1991) Acid phosphatase: endpoint for in vitro toxicity tests. In vitro Cell Dev Biol 27A, 183–184.
Groth, D., Keil, O., Schneider, M., Reszka, R. (1998) Transfection assay for dual determination of toxicity and gene expression. Anal Biochem 258, 141–143.
Bertelmann, E., Ritter, T., Vogt, K., Reszka, R., Hartmann, C., Pleyer, U. (2003) Efficiency of cytokine gene transfer in corneal endothelial cells and organ-cultured corneas mediated by liposomal vehicles and recombinant adenovirus. Ophthal Res 35, 117–124.
Masuda, I., Matsuo, T., Yasuda, T., Matsuo, N. (1996) Gene transfer with liposomes to the intraocular tissues by different routes of administration. Invest Ophthalmol Vis Sci 37, 1914–1920.
Hudde, T., Rayner, S. A., Comer, R. M., (1999) Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium. Gene Ther 6, 939–943.
Gospodarowicz, D., Mescher, A. L., Birdwell, C. R. (1977) Stimulation of corneal endothelial cell proliferation in vitro by fibroblast and epidermal growth factors. Exp Eye Res 25, 75–89.
Fallaux, F. J., Kranenburg, O., Cramer, S. J., (1996) Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 20, 215–222.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Bertelmann, E. (2009). Genetic Manipulation of Corneal Endothelial Cells: Transfection and Viral Transduction. In: Murray, C., Martin, S. (eds) Angiogenesis Protocols. Methods in Molecular Biology, vol 467. Humana Press. https://doi.org/10.1007/978-1-59745-241-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-59745-241-0_13
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-907-9
Online ISBN: 978-1-59745-241-0
eBook Packages: Springer Protocols